Counterpoint Mutual Funds’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
DG
Counterpoint Mutual Funds's HCAT Position: Q4 2023 in Review
Counterpoint Mutual Funds sold out of Health Catalyst (HCAT) in Q4 2023, closing a stake of 24,086 shares — an estimated $244K sold.
Counterpoint Mutual Funds first reported a position in HCAT in Q3 2023 and held it in 1 quarter. The position peaked at $244K in Q3 2023. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2023.
- Counterpoint Mutual Funds reported no remaining Health Catalyst position as of Q4 2023 after selling out during the quarter.
- Counterpoint Mutual Funds sold 24,086 Health Catalyst shares in Q4 2023, an estimated $244K.
- Counterpoint Mutual Funds first reported a position in Health Catalyst in Q3 2023 and held it in 1 quarter.
- Counterpoint Mutual Funds's Health Catalyst position peaked at $244K in Q3 2023.
- 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2023.
Based on Counterpoint Mutual Funds's 13F filing for Q4 2023, filed 7 Feb 2024.